MET and neoplasm: The ligand-dependent heterodimerization of the HER family and c-Met has been extensively demonstrated to activate signaling pathways such as Src, PI3K-AKT-mTOR, and Ras-MAPK, contributing to the invasiveness and metastatic potential of tumor cells [34,81].